Sequenom

Bringing the power of science to healthcare. Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. We serve patients and physicians by providing early patient management information. What makes this vision a reality? Our deep commitment to "Quality of Science." For us, only the highest quality is acceptable. We accept nothing less in the science that supports every product and service we offer. From development to commercialization of innovative tests, "Quality of Science" is the common element in everything we do.
Type
Public
HQ
San Diego, US
Founded
1994
Employees
434 (est)-3%
Sequenom was founded in 1994 and is headquartered in San Diego, US

Sequenom Locations

San Diego, US
Kalamazoo, US
Lansing, US
Tucson, US
Colorado Springs, US
Springfield, US
Nashville, US
Charleston, US
Atlanta, US
Miami, US
Worcester, US
Portland, US
Boston, US
Austin, US
Fort Worth, US
Sacramento, US
Philadelphia, US
New York, US
Salt Lake City, US
Spokane, US

Sequenom Metrics

Sequenom Summary

Market capitalization

$286 M

Closing share price

$2.4
Sequenom's current market capitalization is $286 M.

Sequenom Financials

Sequenom's revenue is $128 M in FY, 2015 which is 15.36% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$162 M$152 M$128 M

Gross profit

$59.7 M$68.1 M$61.3 M

Operating income

$-98.4 M$-13.7 M$-7.88 M

Operating expense total

$158 M$105 M$158 M

Net Income

$-107 M$1.01 M$-16.3 M

Operating cash flow

$-62.2 M$1.72 M$-13 M

    Sequenom Market Value History

    Sequenom Online Presence

    Sequenom News

    Sequenom Company Life